🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Tee Off for Testicular Cancer presented by Fennec Pharma takes place Friday, April 18, at Sewells Point Golf Course in Norfolk, VA. As the title sponsor, we’re proud to join the Testicular Cancer Awareness Foundation in support of this vital cause. …sticularcancerawarenessfoundation.org/tee-off-for-tc…

Are you attending the HOPA Annual Conference or the ONS Congress? Our teams will be onsite and look forward to discussing the importance of managing cisplatin-induced ototoxicity (CIO) as a part of comprehensive cancer care. #HOPA2025 #ONS50 #ONSCongress

Cisplatin is a life-saving chemotherapy, but treatment can result in irreversible hearing loss. Jake shares his experience with #ototoxicity – an unfortunate side effect that affects the majority of cisplatin-treated patients. #ChemoSideEffects #TesticularCancer #CancerWarrior

We’re fiercely committed to the fight against cisplatin-induced ototoxicity (CIO) across the globe. Treating physicians can learn more about our named patient access program here: fennecpharma.com/families/named… #CancerCare #HearingLoss #PatientSupport

We’re excited to join the urology community in Las Vegas tomorrow for #AUA25! Visit our booth to discuss the prevention of cisplatin-induced ototoxicity (CIO) and how we can better support patients undergoing treatment for urologic cancers. #Urology #OncologyPharma #CancerCare

Community oncology is at the heart of cancer care. We’re headed to Orlando for #COA2025 to engage with oncologists, care teams and advocates dedicated to improving patient outcomes. Visit our booth to learn about cisplatin-induced ototoxicity (CIO) management and patient support.

Did you know that routine evaluations for hearing loss are recommended in patients receiving cisplatin? This includes regular audiograms and screening for tinnitus – or ringing in the ears – to catch early signs of cisplatin-induced cytotoxicity. #OnoclogySupport #CancerCare

Today, we reported our financial results for the first quarter of 2025 and provided a business update. Learn more: investors.fennecpharma.com/news-releases/… #Earnings #QuarterlyResults #Investors #Healthcare

Cisplatin is an indispensable component of treatment for many cancers, but it carries a high risk of permanent or irreversible hearing loss. Understanding the science helps us understand the stakes. #OncologySupport #CancerCare #Ototoxicity #ChemoSideEffects

We’re counting down to the ASCO Annual Meeting and looking forward to connecting with oncology leaders, clinicians, and advocates who share our commitment to elevating patient care. #ASCO2025 #OncologySupport #CancerCare

Cisplatin carries the highest risk of ototoxicity of any FDA-approved chemotherapy drug, with studies showing that up to 60-90% of patients treated with it will experience some form of hearing loss. #OncologySupport #CancerCare #Ototoxicity #ChemoSideEffects

The Fennec team has landed at ASCO 2025, and we couldn’t be more energized to be part of the global conversation on advancing cancer care. Stop by booth #37119 and say hello! #ASCO2025 #OncologySupport #CancerCare

Early detection and proactive management of cisplatin-induced ototoxicity (CIO) is a critical part of comprehensive oncology care that can help prevent this life-altering complication. #OncologySupport #CancerCare #Ototoxicity #ChemoSideEffects

This #NationalNursingAssistantsWeek, we recognize the dedication and compassion of those who serve on the frontlines of patient care. We thank you for the vital role you play in supporting patients. #NursingAssistantsWeek #ThankYouCaregivers #OncologySupport

This month, we stand with patients, caregivers, and healthcare teams in raising awareness about sarcomas and bone cancers. #SarcomaAwareness #BoneCancerAwareness #OncologySupport 💛

Early detection and proactive management of cisplatin-induced ototoxicity (CIO) is a critical part of comprehensive oncology care that can help prevent the risk of this complication. #OncologySupport #CancerCare #HearingHealth #Ototoxicity #ChemoSideEffects

On #GlioblastomaAwarenessDay, we join patients, caregivers, and healthcare professionals to help shed light on this very complex and devastating type of brain cancer. Patients with glioblastoma often experience neurologic complications - hearing loss is an additional burden

60-90% of patients treated with cisplatin may experience some form of hearing loss—a side effect known as ototoxicity. While cisplatin is a powerful cancer treatment, its impact on hearing can be life-altering. We’re working to raise awareness and help preserve hearing.